- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 403/02 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings
Patent holdings for IPC class C07D 403/02
Total number of patents in this class: 536
10-year publication summary
|
23
|
19
|
21
|
29
|
23
|
21
|
32
|
37
|
19
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4762 |
12 |
| Bristol-myers Squibb Company | 4886 |
9 |
| Hoffmann-La Roche Inc. | 3252 |
8 |
| Medshine Discovery Inc. | 610 |
8 |
| Array BioPharma Inc. | 529 |
7 |
| Madrigal Pharmaceuticals, Inc. | 82 |
7 |
| Rohm and Haas Electronic Materials Korea Ltd. | 330 |
7 |
| Nerviano Medical Sciences S.r.l. | 253 |
6 |
| Glaxosmithkline LLC | 541 |
5 |
| Janssen Pharmaceutica N.V. | 3625 |
5 |
| The Scripps Research Institute | 1353 |
5 |
| Insilico Medicine IP Limited | 100 |
5 |
| Merck Sharp & Dohme LLC | 3742 |
5 |
| Merck & Co., Inc. | 451 |
4 |
| Merck Sharp & Dohme Corp. | 2218 |
4 |
| Arena Pharmaceuticals, Inc. | 371 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2531 |
4 |
| Duquesne University of the Holy Spirit | 132 |
4 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 274 |
4 |
| RespiVert Ltd. | 79 |
4 |
| Other owners | 419 |